Cytokine Profiling in Immigrants with Clinical Malaria after Extended Periods of Interrupted Exposure to Plasmodium falciparum

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Moncunill, Gemma ^a   Mayor, Alfredo ^a,b   Bardají, Azucena ^a   Puyol, Laura ^a   Nhabomba, Augusto ^b   Barrios, Diana ^a   Aguilar, Ruth ^a,b   Pinazo, María Jesús ^a   Almirall, Mercè ^c   Soler, Cristina ^d   Muñoz, José ^a   Gascón, Joaquim ^a   Dobaño, Carlota ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Ministérioda Saúde   (Mozambique)

^c HOSPITAL ARNAU DE VILANOVA   (Spain)

^d Hospital de Santa Caterina   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; ATOVAQUONE PLUS PROGUANIL; CYTOKINE; DOXYCYCLINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; PYRIMETHAMINE PLUS SULFADOXINE; QUININE; TUMOR NECROSIS FACTOR;

ADULT; AFRICA; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; FEMALE; HUMAN; IMMIGRANT; IMMIGRATION; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PARASITE IMMUNITY; PROTEIN BLOOD LEVEL; SPAIN; TH1 CELL; TRAVEL;

ADULT; BIOLOGICAL MARKERS; CHEMOKINES; CYTOKINES; EMIGRANTS AND IMMIGRANTS; ENDEMIC DISEASES; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PROGNOSIS;

EID: 84881540224     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073360     Document Type: Article

References (41)

1. WHO (2012) World malaria report.
2. Doolan DL, Dobaño C, Baird JK, (2009) Acquired immunity to malaria. Clin Microbiol Rev 22: 13-36. doi:10.1128/CMR.00025-08. PubMed: 19136431.
3. Langhorne J, Ndungu FM, Sponaas A-M, Marsh K, (2008) Immunity to malaria: more questions than answers. Nat Immunol 9: 725-732. doi:10.1038/ni.f.205. PubMed: 18563083.
4. Spence PJ, Langhorne J, (2012) T cell control of malaria pathogenesis. Curr Top Microbiol Immunol, 355: 3-7. PubMed: 21809194.
5. Dodoo D, Omer FM, Todd J, Akanmori BD, Koram Ka, et al. (2002) Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. J Infect Dis 185: 971-979. doi:10.1086/339408. PubMed: 11920322.
6. Day NP, Hien TT, Schollaardt T, Loc PP, Chuong LV, et al. (1999) The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J Infect Dis 180: 1288-1297. doi:10.1086/315016. PubMed: 10479160.
7. Robinson LJ, D'Ombrain MC, Stanisic DI, Taraika J, Bernard N, et al. (2009) Cellular tumor necrosis factor, gamma interferon, and interleukin-6 responses as correlates of immunity and risk of clinical Plasmodium falciparum malaria in children from Papua New Guinea. Infect Immun 77: 3033-3043. doi:10.1128/IAI.00211-09. PubMed: 19380468.
8. Rovira-Vallbona E, Moncunill G, Bassat Q, Aguilar R, Machevo S, et al. (2012) Low antibodies against Plasmodium falciparum and imbalanced pro-inflammatory cytokines are associated with severe malaria in Mozambican children: a case-control study. Malar J 11: 181. doi:10.1186/1475-2875-11-181. PubMed: 22646809.
9. Jennings RM, De Souza JB, Todd JE, Armstrong M, Flanagan KL, et al. (2006) Imported Plasmodium falciparum malaria: are patients originating from disease-endemic areas less likely to develop severe disease? A prospective, observational study. Am J Trop Med Hyg 75: 1195-1199. PubMed: 17172392.
10. Matteelli, a, Colombini P, Gulletta M, Castelli F, Carosi G (1999) Epidemiological features and case management practices of imported malaria in northern Italy 1991-1995. Trop Med Int Health 4: 653-657. doi:10.1046/j.1365-3156.1999.00468.x. PubMed: 10583898.
11. Jelinek T, Schulte C, Behrens R, Grobusch MP, Coulaud JP, et al. (2002) Imported Falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases. Clin Infect Dis 34: 572-576. doi:10.1086/338235. PubMed: 11803507.
12. MacMullin G, Mackenzie R, Lau R, Khang J, Zhang H, et al. (2012) Host immune response in returning travellers infected with malaria. Malar J 11: 148. doi:10.1186/1475-2875-11-148. PubMed: 22554058.
13. Mascarello M, Allegranzi B, Angheben A, Anselmi M, Concia E, et al. (2008) Imported malaria in adults and children: epidemiological and clinical characteristics of 380 consecutive cases observed in Verona, Italy. J Travel Med 15: 229-236. doi:10.1111/j.1708-8305.2008.00204.x. PubMed: 18666922.
14. Bouchaud O, Cot M, Kony S, Durand R, Schiemann R, et al. (2005) Do African immigrants living in France have long-term malarial immunity? Am J Trop Med Hyg 72: 21-25. PubMed: 15728861.
15. Salvadó E, Pinazo MJ, Muñoz J, Alonso D, Naniche D, et al. (2008) Clinical presentation and complications of Plasmodium falciparum malaria in two populations: travelers and immigrants. Enferm Infecc Microbiol Clin 26: 282-284. doi:10.1157/13120415. PubMed: 18479645.
16. Monge-Maillo B, Norman F, Pérez-Molina JA, Díaz-Menéndez M, Rubio JM, et al. (2012) Plasmodium falciparum in asymptomatic immigrants from sub-Saharan Africa, Spain. Parasite Immunol 18: 356-357. PubMed: 22305463.
17. Kleinschmidt I, Sharp B, (2001) Patterns in age-specific malaria incidence in a population exposed to low levels of malaria transmission intensity. Trop Med Int Health 6: 986-991. doi:10.1046/j.1365-3156.2001.00817.x. PubMed: 11737835.
18. Luxemburger C, Ricci F, Nosten F, Raimond D, Bathet S, et al. (1997) The epidemiology of severe malaria in an area of low transmission in Thailand. Trans R Soc Trop Med Hyg 91: 256-262. doi:10.1016/S0035-9203(97)90066-3. PubMed: 9231189.
19. Deloron P, Chougnet C, (1992) Is immunity to malaria really short-lived? Parasitol Today 8: 375-378. doi:10.1016/0169-4758(92)90174-Z. PubMed: 15463545.
20. Teirlinck AC, McCall MBB, Roestenberg M, Scholzen A, Woestenenk R, et al. (2011) Longevity and Composition of Cellular Immune Responses Following Experimental Plasmodium falciparum Malaria Infection in Humans. PLOS Pathog 7: e1002389. PubMed: 22144890.
21. Wipasa J, Okell L, Sakkhachornphop S, Suphavilai C, Chawansuntati K, et al. (2011) Short-Lived IFN-γ Effector Responses, but Long-Lived IL-10 Memory Responses, to Malaria in an Area of Low Malaria Endemicity. PLOS Pathog 7: e1001281. PubMed: 21347351.
22. Walther M, Jeffries D, Finney OC, Njie M, Ebonyi A, et al. (2009) Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria. PLOS Pathog 5: e1000364. PubMed: 19343213.
23. Moncunill G, Mayor A, Jiménez A, Nhabomba A, Puyol L, et al. (2013) Cytokine and Antibody Responses to Plasmodium falciparum in Naïve Individuals during a First Malaria Episode: Effect of Age and Malaria Exposure. PLOS ONE 8: e55756. doi:10.1371/journal.pone.0055756. PubMed: 23437061.
24. Mayor A, Rovira-Vallbona E, Srivastava A, Sharma SK, Pati SS, et al. (2009) Functional and immunological characterization of a Duffy binding-like alpha domain from Plasmodium falciparum erythrocyte membrane protein 1 that mediates rosetting. Infect Immun 77: 3857-3863. doi:10.1128/IAI.00049-09. PubMed: 19546191.
25. Berthoud TK, Manaca MN, Quelhas D, Aguilar R, Guinovart C, et al. (2011) Comparison of commercial kits to measure cytokine responses to Plasmodium falciparum by multiplex microsphere suspension array technology. Malar J 10: 115. doi:10.1186/1475-2875-10-115. PubMed: 21554671.
26. Moncunill G, Mayor A, Jiménez A, Nhabomba A, Casas-Vila N, et al. (2013) High antibody responses against Plasmodium falciparum in immigrants after extended periods of interrupted exposure to malaria. PLOS ONE 8: e73624.
27. De Jager W, Bourcier K, Rijkers GT, Prakken BJ, Seyfert-Margolis V, (2009) Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol 10: 52. doi:10.1186/1471-2172-10-52. PubMed: 19785746.
28. Skogstrand K, (2012) Multiplex assays of inflammatory markers, a description of methods and discussion of precautions- Our experience through the last ten years. Methods 56: 204-212. doi:10.1016/j.ymeth.2011.09.025. PubMed: 22001645.
29. Mantovani A, Bussolino F, Dejana E, (1992) Cytokine regulation of endothelial cell function. FASEB J 6: 2591-2599. PubMed: 1592209.
30. Netea MG, Kullberg BJ, Van der Meer JW, (2000) Circulating cytokines as mediators of fever. Clin Infect Dis Off Publ Infect Dis Soc Am 31 (Suppl 5):: S178-S184. doi:10.1086/317513. PubMed: 11113021.
31. Clark IA, Budd AC, Alleva LM, Cowden WBClark I a, Budd AC, Alleva LM, Cowden WB (2006) Human malarial disease: a consequence of inflammatory cytokine release. Malar J 5: 85. doi:10.1186/1475-2875-5-85. PubMed: 17029647.
32. Prakash D, Fesel C, Jain R, Cazenave P-A, Mishra GC, et al. (2006) Clusters of cytokines determine malaria severity in Plasmodium falciparum-infected patients from endemic areas of Central India. J Infect Dis 194: 198-207. doi:10.1086/504720. PubMed: 16779726.
33. Lyke KE, Burges R, Cissoko Y, Sangare L, Dao M, et al. (2004) Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect Immun 72: 5630-5637. doi:10.1128/IAI.72.10.5630-5637.2004. PubMed: 15385460.
34. Torre D, Speranza F, Giola M, Matteelli A, Tambini R, et al. (2002). ole Th 1 and Th2 cytokines in immune response to uncomplicated Plasmodium falciparum malaria. 9: 348.
35. Boutlis CS, Yeo TW, Anstey NM, (2006) Malaria tolerance--for whom the cell tolls? Trends Parasitol 22: 371-377. doi:10.1016/j.pt.2006.06.002. PubMed: 16784889.
36. Migot F, Chougnet C, Raharimalala L, Astagneau P, Lepers JP, et al. (1993) Human immune responses to the Plasmodium falciparum ring-infected erythrocyte surface antigen (Pf155/RESA) after a decrease in malaria transmission in Madagascar. Am J Trop Med Hyg 48: 432-439. PubMed: 8470778.
37. Migot F, Chougnet C, Henzel D, Dubois B, Jambou R, et al. (1995) Anti-malaria antibody-producing B cell frequencies in adults after a Plasmodium falciparum outbreak in Madagascar. Clin Exp Immunol 102: 529-534. PubMed: 8536368.
38. Wipasa J, Suphavilai C, Okell LC, Cook J, Corran PH, et al. (2010) Long-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax. PLOS Pathog 6: e1000770.
39. Boutlis CS, Gowda DC, Naik RS, Maguire GP, Mgone CS, et al. (2002) Antibodies to Plasmodium falciparum glycosylphosphatidylinositols: inverse association with tolerance of parasitemia in Papua New Guinean children and adults. Infect Immun 70: 5052-5057. doi:10.1128/IAI.70.9.5052-5057.2002. PubMed: 12183552.
40. De Souza JB, Todd J, Krishegowda G, Gowda DC, Kwiatkowski D, et al. (2002) Prevalence and boosting of antibodies to Plasmodium falciparum glycosylphosphatidylinositols and evaluation of their association with protection from mild and severe clinical malaria. Infect Immun 70: 5045-5051. doi:10.1128/IAI.70.9.5045-5051.2002. PubMed: 12183551.
41. McCall MBB, Sauerwein RW, (2010) Interferon-γ--central mediator of protective immune responses against the pre-erythrocytic and blood stage of malaria. J Leukoc Biol 88: 1131-1143. doi:10.1189/jlb.0310137. PubMed: 20610802.